Search Results - "Dellinger T"

This result is not displayed to guests.
Login for full access.

HIPEC treatment in advanced and recurrent ovarian cancer: a meta-analysis of observational studies.

Authors: Dellinger, T. H. Smith, D. D. Ballard, E. et al.

Source: European Journal of Gynaecological Oncology. 2018, Vol. 39 Issue 3, p353-360. 8p.

Computation of nonequilibrium merged stagnation shock layers by successive accelerated replacement.

Authors: Dellinger, T. C.

Source: AIAA Journal; February 1971, Vol. 9, p262-269, 8p

Big hole drilling, a study in depth.

Authors: Dellinger, T. B.

Source: Mining Engineering; December 1965, Vol. 17, p71-75, 5p

Diamond bit drilling research.

Authors: Dellinger, T. B. Livesay, B. J.

Source: Journal of Engineering for Industry; February 1973, Vol. 95, p256-262, 7p

For shaft sinking.

Authors: Dellinger, T. B.

Source: Engineering & Mining Journal (00958948); March 1966, Vol. 167, p76-86, 11p

Unique materials mix used to seal large diameter casing in borehole.

Authors: Dellinger, T. B. Boughton, L. D.

Source: Engineering & Mining Journal (00958948); June 1965, Vol. 166, p114-118, 5p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Directional technology will extend drilling reach.

Authors: Dellinger, T. B.

Source: Oil & Gas Journal; September 15 1980, Vol. 78, p153

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Quality of life (QoL) in ovarian cancer patients following hyperthermic intraperitoneal chemotherapy (HIPEC) versus intraperitoneal (IP) chemotherapy.

Authors: Dellinger, T. Lee, S.J. Sun, V. et al.

Source: Gynecologic Oncology. Jul2019:Supplement 1, Vol. 154, p214-214. 1p.

Therapeutic potential of ruxolitinib in human ovarian cancer.

Authors: Han, E.S. Dellinger, T. Wen, W. et al.

Source: Gynecologic Oncology. Jun2016 Supplement 1, Vol. 141, p45-46. 2p.

Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer.

Authors: Adamson, A. W. Ding, Y. C. Steele, L. et al.

Source: Journal of Ovarian Research. 7/17/2023, Vol. 16 Issue 1, p1-14. 14p.

Family history of cancer as a predictor for poor survival among young women with endometrial cancer (EC)

Authors: Dellinger, T. Chase, D. Stablein, G. et al.

Source: Gynecologic Oncology. Mar2010, Vol. 116 Issue 3, p594-595. 2p.

This result is not displayed to guests.
Login for full access.

Dkk3 Wnt inhibitor expression in endometrial cancer predicts pelvic lymph node status, and correlates with clinicopathologic factors

Authors: Dellinger, T. Planutis, K. Monk, B. et al.

Source: Gynecologic Oncology. Oct2012, Vol. 127 Issue 1, pS20-S20. 1p.

Novel expression pattern of the Wnt inhibitors secreted frizzled related protein 1 and 4 (SFRP1,4) in endometrial cancer—A potential role as markers of progression

Authors: Dellinger, T. Eskander, R. Planutis, K. et al.

Source: Gynecologic Oncology. Mar2012 Supplement, Vol. 125, pS144-S144. 1p.

Expression patterns of the Wnt pathway inhibitors Dickkopf3 (Dkk3) and secreted frizzled-related proteins (SFRP) 1 and 4 in endometrial endometrioid adenocarcinoma: A Gynecologic Oncology Group study

Authors: Dellinger, T. Eskander, R. Ali, S. et al.

Source: Gynecologic Oncology. Mar2012 Supplement, Vol. 125, pS141-S141. 1p.